![Image of Covid virus](https://public4.pagefreezer.com:443/content/FDA/13-12-2021T17:36/https://www.fda.gov/files/styles/medium_3/public/covid19-1600x900_0.jpg?itok=T99M5Ghy)
Omicron Variant: COVID Molecular Tests That May Be Impacted
Dec 3 – The performance of certain EUA-authorized molecular tests may be impacted by mutations in the omicron variant.
Learn more about devices such as diagnostic tests, ventilators, and personal protective equipment (PPE)—including surgical masks, face shields, respirators, gowns, and gloves.
Learn MoreDec 3 – The performance of certain EUA-authorized molecular tests may be impacted by mutations in the omicron variant.
Nov 15 – FDA updates test policies to help ensure accuracy & reliability of tests, increase access to at-home tests.
EUAs make available diagnostic tests, respirators, ventilators, and related devices for COVID-19.
Nov 16 – FDA authorized marketing of EaseVRx to help with pain reduction in adults with chronic lower back pain.
Nov 12 – Update provides additional info on the recall of ventilators, BiPAP, CPAP machines, recommendations for users.
Oct 29 - Before choosing implants, talk to your dental provider about potential benefits and risks of the procedure.
Information and news on device recalls, other safety issues, approvals, and other device and radiation-emitting product topics.